Expression of EEF1A1 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

EEF1A1 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 9646.19

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

8200.9

Number of samples

141

Samples

Sample	Description	pTPM
TCGA-06-2569-01A	24 years, female, black or african american, stage:'--, alive, 13 days	21284.7
TCGA-14-0871-01A	74 years, female, white, stage:'--, dead, 880 days	16921.8
TCGA-06-5417-01A	45 years, female, white, stage:'--, alive, 155 days	14957.4
TCGA-12-3650-01A	46 years, male, white, stage:'--, dead, 333 days	14433.9
TCGA-27-2521-01A	34 years, male, white, stage:'--, dead, 510 days	13680.2
TCGA-14-1829-01A	57 years, male, black or african american, stage:'--, alive, 218 days	13315.5
TCGA-06-0178-01A	38 years, male, white, stage:'--, dead, 2681 days	12799.9
TCGA-12-3652-01A	60 years, male, white, stage:'--, dead, 1062 days	12506.7
TCGA-19-2620-01A	70 years, male, white, stage:'--, dead, 148 days	12300.2
TCGA-27-1831-01A	66 years, male, white, stage:'--, dead, 505 days	11971.6
TCGA-14-2554-01A	52 years, female, white, stage:'--, dead, 532 days	11831.5
TCGA-12-5295-01A	60 years, female, white, stage:'--, dead, 454 days	11775.2
TCGA-28-5208-01A	52 years, male, white, stage:'--, dead, 544 days	11553.0
TCGA-06-5418-01A	75 years, female, white, stage:'--, dead, 83 days	11294.9
TCGA-02-0055-01A	62 years, female, white, stage:'--, dead, 76 days	11133.3
TCGA-06-2570-01A	21 years, female, white, stage:'--, alive, 958 days	11120.1
TCGA-06-0174-01A	54 years, male, white, stage:'--, dead, 98 days	11117.4
TCGA-32-2634-01A	82 years, male, white, stage:'--, alive, 693 days	11027.4
TCGA-32-2638-01A	67 years, male, white, stage:'--, dead, 766 days	10822.8
TCGA-32-4213-01A	47 years, female, white, stage:'--, alive, 604 days	10816.1
TCGA-06-0238-01A	46 years, male, white, stage:'--, dead, 405 days	10657.7
TCGA-06-2565-01A	59 years, male, asian, stage:'--, dead, 506 days	10622.3
TCGA-02-2485-01A	53 years, male, black or african american, stage:'--, alive, 470 days	10621.5
TCGA-14-0817-01A	69 years, female, white, stage:'--, dead, 164 days	10621.0
TCGA-06-0210-01A	72 years, female, white, stage:'--, dead, 225 days	10482.1
TCGA-06-0211-01A	47 years, male, white, stage:'--, dead, 360 days	10395.3
TCGA-12-3653-01A	34 years, female, white, stage:'--, dead, 442 days	10254.6
TCGA-06-0139-01A	40 years, male, white, stage:'--, dead, 362 days	10230.4
TCGA-06-0744-01A	66 years, male, white, stage:'--, dead, 1426 days	10222.5
TCGA-32-5222-01A	66 years, male, white, stage:'--, dead, 585 days	10179.9
TCGA-41-3915-01A	48 years, male, white, stage:'--, dead, 360 days	10070.8
TCGA-27-2528-01A	62 years, male, white, stage:'--, dead, 480 days	10056.4
TCGA-02-2483-01A	43 years, male, asian, stage:'--, alive, 466 days	10042.4
TCGA-06-5414-01A	61 years, male, white, stage:'--, alive, 273 days	9928.3
TCGA-12-0618-01A	49 years, male, white, stage:'--, dead, 395 days	9824.9
TCGA-14-0789-01A	54 years, male, white, stage:'--, dead, 342 days	9788.7
TCGA-06-2563-01A	72 years, female, white, stage:'--, alive, 932 days	9692.6
TCGA-41-5651-01A	59 years, female, black or african american, stage:'--, dead, 460 days	9686.3
TCGA-06-0125-01A	63 years, female, white, stage:'--, dead, 1448 days	9673.0
TCGA-32-1982-01A	76 years, female, white, stage:'--, dead, 142 days	9619.4
TCGA-26-5139-01A	65 years, female, white, stage:'--, alive, 48 days	9585.4
TCGA-76-4927-01A	58 years, male, white, stage:'--, dead, 535 days	9495.3
TCGA-14-1823-01A	58 years, female, white, stage:'--, dead, 543 days	9482.3
TCGA-28-5207-01A	71 years, male, white, stage:'--, dead, 343 days	9472.9
TCGA-12-0616-01A	36 years, female, white, stage:'--, dead, 448 days	9419.8
TCGA-06-0747-01A	53 years, male, white, stage:'--, dead, 82 days	9239.6
TCGA-27-2524-01A	56 years, male, white, stage:'--, dead, 231 days	9195.5
TCGA-76-4932-01A	50 years, female, white, stage:'--, dead, 1458 days	9130.2
TCGA-06-0190-01A	62 years, male, white, stage:'--, dead, 317 days	9086.8
TCGA-06-0645-01A	55 years, female, white, stage:'--, dead, 175 days	9014.7
TCGA-32-2632-01A	80 years, male, white, stage:'--, dead, 269 days	8964.7
TCGA-14-1825-01A	70 years, male, white, stage:'--, dead, 232 days	8853.1
TCGA-06-0219-01A	67 years, male, white, stage:'--, dead, 22 days	8786.4
TCGA-06-2558-01A	75 years, female, white, stage:'--, dead, 380 days	8739.2
TCGA-02-2486-01A	64 years, male, white, stage:'--, dead, 618 days	8719.2
TCGA-27-2526-01A	79 years, female, white, stage:'--, dead, 87 days	8703.9
TCGA-28-5216-01A	52 years, male, white, stage:'--, alive, 415 days	8513.2
TCGA-28-2513-01A	69 years, female, white, stage:'--, alive, 222 days	8513.1
TCGA-06-0686-01A	53 years, male, white, stage:'--, dead, 432 days	8511.1
TCGA-12-5299-01A	56 years, female, white, stage:'--, dead, 98 days	8465.4
TCGA-27-2523-01A	63 years, male, white, stage:'--, dead, 489 days	8454.9
TCGA-06-0158-01A	73 years, male, white, stage:'--, dead, 329 days	8286.4
TCGA-12-0821-01A	62 years, male, white, stage:'--, dead, 323 days	8231.0
TCGA-06-0156-01A	57 years, male, white, stage:'--, dead, 178 days	8164.5
TCGA-14-1034-01A	60 years, female, stage:'--, dead, 485 days	8104.3
TCGA-06-0138-01A	43 years, male, white, stage:'--, dead, 737 days	8083.7
TCGA-06-2559-01A	83 years, male, white, stage:'--, dead, 150 days	8055.2
TCGA-06-0168-01A	59 years, female, white, stage:'--, dead, 598 days	8043.6
TCGA-28-5218-01A	63 years, male, white, stage:'--, dead, 157 days	7991.8
TCGA-06-0129-01A	30 years, male, asian, stage:'--, dead, 1024 days	7762.6
TCGA-28-2509-01A	77 years, female, white, stage:'--, alive, 145 days	7744.5
TCGA-06-0745-01A	59 years, male, white, stage:'--, dead, 239 days	7664.4
TCGA-06-2564-01A	50 years, male, white, stage:'--, alive, 181 days	7661.6
TCGA-19-5960-01A	56 years, male, white, stage:'--, dead, 455 days	7617.1
TCGA-41-2571-01A	89 years, male, white, stage:'--, dead, 26 days	7600.7
TCGA-27-1830-01A	57 years, male, white, stage:'--, dead, 154 days	7595.1
TCGA-06-0132-01A	49 years, male, white, stage:'--, dead, 771 days	7572.1
TCGA-19-2619-01A	55 years, female, black or african american, stage:'--, alive, 294 days	7487.0
TCGA-19-1390-01A	63 years, female, white, stage:'--, dead, 772 days	7479.1
TCGA-28-2514-01A	45 years, male, asian, stage:'--, alive, 160 days	7359.9
TCGA-26-5132-01A	74 years, male, white, stage:'--, alive, 286 days	7349.2
TCGA-06-5416-01A	23 years, female, white, stage:'--, alive, 204 days	7302.3
TCGA-19-4065-01A	36 years, male, white, stage:'--, alive, 214 days	7269.9
TCGA-41-2572-01A	67 years, male, white, stage:'--, dead, 406 days	7256.6
TCGA-06-0157-01A	63 years, female, white, stage:'--, dead, 97 days	7242.2
TCGA-26-5133-01A	59 years, male, white, stage:'--, alive, 452 days	7211.9
TCGA-76-4925-01A	76 years, male, white, stage:'--, dead, 146 days	7116.9
TCGA-06-2567-01A	65 years, male, white, stage:'--, dead, 133 days	6990.5
TCGA-08-0386-01A	74 years, male, white, stage:'--, dead, 548 days	6913.5
TCGA-06-5413-01A	67 years, male, white, stage:'--, alive, 268 days	6881.7
TCGA-06-5408-01A	54 years, female, white, stage:'--, dead, 357 days	6868.8
TCGA-06-0878-01A	74 years, male, white, stage:'--, alive, 218 days	6813.8
TCGA-27-1834-01A	56 years, male, white, stage:'--, dead, 1233 days	6737.8
TCGA-32-2615-01A	62 years, male, white, stage:'--, dead, 485 days	6721.7
TCGA-06-5412-01A	78 years, female, white, stage:'--, dead, 138 days	6698.1
TCGA-06-5858-01A	45 years, female, white, stage:'--, alive, 187 days	6686.9
TCGA-06-0184-01A	63 years, male, white, stage:'--, dead, 2126 days	6676.9
TCGA-14-0787-01A	69 years, male, asian, stage:'--, dead, 68 days	6624.4
TCGA-28-5215-01A	62 years, female, white, stage:'--, dead, 335 days	6569.6
TCGA-28-1753-01A	53 years, male, white, stage:'--, alive, 37 days	6508.5
TCGA-06-0882-01A	30 years, male, white, stage:'--, dead, 632 days	6492.6
TCGA-32-1970-01A	59 years, male, white, stage:'--, dead, 468 days	6477.4
TCGA-06-0130-01A	54 years, male, white, stage:'--, dead, 394 days	6397.0
TCGA-06-5411-01A	51 years, male, white, stage:'--, dead, 254 days	6361.2
TCGA-12-0619-01A	60 years, male, white, stage:'--, dead, 1062 days	6305.3
TCGA-06-2562-01A	81 years, male, white, stage:'--, dead, 382 days	6289.0
TCGA-27-1835-01A	53 years, female, white, stage:'--, dead, 648 days	6239.4
TCGA-02-0047-01A	78 years, male, white, stage:'--, dead, 448 days	6140.2
TCGA-06-5410-01A	72 years, female, white, stage:'--, dead, 108 days	6110.4
TCGA-06-0644-01A	71 years, male, black or african american, stage:'--, dead, 384 days	6109.2
TCGA-19-2629-01A	60 years, male, white, stage:'--, dead, 737 days	6106.7
TCGA-32-2616-01A	48 years, female, white, stage:'--, dead, 224 days	5995.8
TCGA-26-1442-01A	43 years, male, white, stage:'--, alive, 953 days	5912.5
TCGA-06-5856-01A	58 years, male, white, stage:'--, dead, 114 days	5883.3
TCGA-26-5134-01A	74 years, male, white, stage:'--, alive, 167 days	5830.3
TCGA-19-2625-01A	76 years, female, white, stage:'--, dead, 124 days	5808.8
TCGA-06-0646-01A	60 years, male, white, stage:'--, dead, 175 days	5799.5
TCGA-06-0749-01A	50 years, male, black or african american, stage:'--, dead, 82 days	5740.9
TCGA-27-1837-01A	36 years, male, white, stage:'--, dead, 427 days	5720.9
TCGA-76-4931-01A	70 years, female, white, stage:'--, dead, 279 days	5666.0
TCGA-06-5859-01A	63 years, male, white, stage:'--, alive, 139 days	5635.8
TCGA-15-1444-01A	21 years, male, white, stage:'--, dead, 1537 days	5617.1
TCGA-28-5209-01A	66 years, female, white, stage:'--, alive, 442 days	5504.5
TCGA-26-5135-01A	72 years, female, white, stage:'--, dead, 270 days	5417.0
TCGA-06-0743-01A	69 years, male, white, stage:'--, dead, 803 days	5348.4
TCGA-28-5204-01A	72 years, male, white, stage:'--, dead, 454 days	5333.9
TCGA-41-4097-01A	63 years, female, white, stage:'--, dead, 6 days	5122.0
TCGA-16-0846-01A	85 years, male, white, stage:'--, dead, 119 days	5098.9
TCGA-19-2624-01A	51 years, male, white, stage:'--, dead, 5 days	4997.7
TCGA-15-0742-01A	65 years, male, white, stage:'--, dead, 419 days	4939.2
TCGA-27-2519-01A	48 years, male, white, stage:'--, dead, 550 days	4867.0
TCGA-06-2557-01A	76 years, male, black or african american, stage:'--, dead, 33 days	4846.4
TCGA-32-1980-01A	72 years, male, white, stage:'--, dead, 36 days	4841.9
TCGA-06-0141-01A	62 years, male, white, stage:'--, dead, 313 days	4575.7
TCGA-06-0187-01A	69 years, male, white, stage:'--, dead, 828 days	4513.3
TCGA-28-5220-01A	67 years, male, white, stage:'--, dead, 388 days	4380.1
TCGA-06-1804-01A	81 years, female, white, stage:'--, dead, 414 days	4135.7
TCGA-06-0750-01A	43 years, male, white, stage:'--, dead, 28 days	4113.9
TCGA-27-1832-01A	59 years, female, white, stage:'--, dead, 300 days	3838.1
TCGA-76-4929-01A	76 years, female, white, stage:'--, dead, 111 days	3627.1
TCGA-06-2561-01A	53 years, female, white, stage:'--, dead, 537 days	3568.2
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

EEF1A1 is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 5185.7

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

4786.2

Number of samples

Samples

Sample	Description	pTPM
AK156	N, NA, stage:NA, dead, 330 days	9327.3
AK066	N, NA, stage:NA, alive, 960 days	9309.2
AK049	N, NA, stage:NA, dead, 180 days	8544.9
AK142	N, NA, stage:NA, alive, 90 days	8203.3
AK139	N, NA, stage:NA, dead, 270 days	7559.1
AK074	N, NA, stage:NA, alive, 300 days	7189.7
AK124	N, NA, stage:NA, alive, 1920 days	7138.1
AK165	N, NA, stage:NA, alive, 360 days	6807.8
AK133	N, NA, stage:NA, dead, 360 days	6802.0
AK178	N, NA, stage:NA, dead, 240 days	6713.4
AK055	N, NA, stage:NA, dead, 240 days	6446.8
AK072	N, NA, stage:NA, dead, 150 days	6274.4
AK051	N, NA, stage:NA, dead, 360 days	6225.0
AK098	N, NA, stage:NA, dead, 660 days	6099.9
AK195	N, NA, stage:NA, dead, 390 days	5744.7
AK231	N, NA, stage:NA, dead, 240 days	5641.2
AK043	N, NA, stage:NA, alive, 660 days	5518.3
AK088	N, NA, stage:NA, dead, 360 days	5421.5
AK185	N, NA, stage:NA, alive, 330 days	5343.1
AK188	N, NA, stage:NA, alive, 420 days	5292.0
AK183	N, NA, stage:NA, alive, 360 days	5285.6
AK041	N, NA, stage:NA, alive, 810 days	5254.1
AK213	N, NA, stage:NA, alive, 2010 days	5211.5
AK199	N, NA, stage:NA, alive, 1860 days	5205.2
AK236	N, NA, stage:NA, dead, 360 days	5166.2
AK158	N, NA, stage:NA, dead, 360 days	4942.4
AK173	N, NA, stage:NA, dead, 180 days	4868.0
AK030	N, NA, stage:NA, dead, 120 days	4779.3
AK071	N, NA, stage:NA, dead, 540 days	4652.2
AK149	N, NA, stage:NA, dead, 420 days	4524.2
AK216	N, NA, stage:NA, dead, 360 days	4426.7
AK003	N, NA, stage:NA, dead, 600 days	4372.5
AK100	N, NA, stage:NA, alive, 960 days	4174.0
AK091	N, NA, stage:NA, dead, 210 days	4026.7
AK167	N, NA, stage:NA, dead, 180 days	3863.5
AK053	N, NA, stage:NA, dead, 300 days	3825.3
AK002	N, NA, stage:NA, dead, 570 days	3682.8
AK227	N, NA, stage:NA, alive, 300 days	3618.9
AK081	N, NA, stage:NA, dead, 180 days	3563.0
AK102	N, NA, stage:NA, alive, 1740 days	3453.3
AK123	N, NA, stage:NA, dead, 180 days	3398.2
AK089	N, NA, stage:NA, dead, 330 days	3394.2
AK068	N, NA, stage:NA, alive, 360 days	3338.5
AK218	N, NA, stage:NA, dead, 180 days	3324.9
AK076	N, NA, stage:NA, alive, 660 days	3320.9
AK205	N, NA, stage:NA, dead, 120 days	3225.1
AK103	N, NA, stage:NA, alive, 1320 days	3197.8
AK079	N, NA, stage:NA, dead, 210 days	3190.0
AK153	N, NA, stage:NA, dead, 240 days	3042.6
AK134	N, NA, stage:NA, dead, 360 days	3020.3
AK015	N, NA, stage:NA, alive, 720 days	2918.5
AK006	N, NA, stage:NA, dead, 360 days	2905.1
AK035	N, NA, stage:NA, dead, 210 days	2674.7
AK085	N, NA, stage:NA, alive, 660 days	2663.1
AK226	N, NA, stage:NA, dead, 360 days	2655.2
AK005	N, NA, stage:NA, dead, 240 days	2555.6
AK117	N, NA, stage:NA, dead, 210 days	2475.5
AK099	N, NA, stage:NA, dead, 420 days	1805.6
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0217000004	Tumor	0.9
CPT0162100003	Tumor	0.7
CPT0087570003	Tumor	0.5
CPT0189460003	Tumor	0.5
CPT0093360003	Tumor	0.5
CPT0087950003	Tumor	0.5
CPT0168380003	Tumor	0.4
CPT0089150003	Tumor	0.4
CPT0205450004	Tumor	0.4
CPT0087730003	Tumor	0.4
CPT0206780003	Tumor	0.3
CPT0162020003	Tumor	0.3
CPT0206560003	Tumor	0.3
CPT0205780003	Tumor	0.3
CPT0002410011	Tumor	0.3
CPT0127480003	Tumor	0.3
CPT0205570003	Tumor	0.3
CPT0125220003	Tumor	0.3
CPT0093510003	Tumor	0.3
CPT0206230003	Tumor	0.3
CPT0221180003	Tumor	0.3
CPT0206110003	Tumor	0.3
CPT0206880003	Tumor	0.3
CPT0206000004	Tumor	0.2
CPT0190360004	Tumor	0.2
CPT0217060003	Tumor	0.2
CPT0189650004	Tumor	0.2
CPT0127420003	Tumor	0.2
CPT0087680003	Tumor	0.2
CPT0064890003	Tumor	0.2
CPT0207090003	Tumor	0.2
CPT0125570003	Tumor	0.2
CPT0167640003	Tumor	0.2
CPT0168830003	Tumor	0.2
CPT0175060003	Tumor	0.2
CPT0189850004	Tumor	0.1
CPT0064650003	Tumor	0.1
CPT0225730003	Tumor	0.1
CPT0167530003	Tumor	0.1
CPT0219080004	Tumor	0.1
CPT0217100003	Tumor	0.1
CPT0206450003	Tumor	0.1
CPT0218690004	Tumor	0.1
CPT0167970003	Tumor	0.1
CPT0189570004	Tumor	0.1
CPT0079790003	Tumor	0.1
CPT0218670003	Tumor	0.1
CPT0092440003	Tumor	0.1
CPT0186100003	Tumor	0.0
CPT0224540004	Tumor	0.0
CPT0217880003	Tumor	0.0
CPT0224390004	Tumor	0.0
CPT0217430008	Tumor	0.0
CPT0196850003	Tumor	0.0
CPT0125510003	Tumor	0.0
CPT0071100003	Tumor	0.0
CPT0224600003	Tumor	0.0
CPT0218770003	Tumor	0.0
CPT0217710008	Tumor	0.0
CPT0216920008	Tumor	0.0
CPT0078580003	Tumor	-0.1
CPT0161730003	Tumor	-0.1
CPT0225760003	Tumor	-0.1
CPT0182550003	Tumor	-0.1
CPT0208980003	Tumor	-0.1
CPT0217190003	Tumor	-0.1
CPT0168270003	Tumor	-0.1
CPT0224330003	Tumor	-0.1
CPT0206330003	Tumor	-0.1
CPT0189750004	Tumor	-0.1
CPT0218890004	Tumor	-0.1
CPT0093550003	Tumor	-0.1
CPT0201710003	Tumor	-0.1
CPT0182580003	Tumor	-0.1
CPT0093450003	Tumor	-0.1
CPT0123530003	Tumor	-0.1
CPT0182500003	Tumor	-0.2
CPT0205890003	Tumor	-0.2
CPT0205670004	Tumor	-0.2
CPT0162140003	Tumor	-0.2
CPT0189250003	Tumor	-0.2
CPT0218960004	Tumor	-0.2
CPT0228220003	Tumor	-0.2
CPT0167860004	Tumor	-0.2
CPT0093590003	Tumor	-0.2
CPT0171580008	Tumor	-0.2
CPT0218330004	Tumor	-0.2
CPT0209440003	Tumor	-0.2
CPT0168720003	Tumor	-0.3
CPT0168480003	Tumor	-0.3
CPT0199770003	Tumor	-0.3
CPT0104330003	Tumor	-0.3
CPT0104220003	Tumor	-0.3
CPT0167750004	Tumor	-0.3
CPT0168080003	Tumor	-0.3
CPT0207030003	Tumor	-0.4
CPT0218830004	Tumor	-0.4
CPT0204350003	Normal	-0.4
CPT0168590003	Tumor	-0.4
CPT0204380003	Normal	-0.4
CPT0206670004	Tumor	-0.5
CPT0204370003	Normal	-0.5
CPT0190240004	Tumor	-0.5
CPT0204390003	Normal	-0.6
CPT0204330003	Normal	-0.6
CPT0204400003	Normal	-0.6
CPT0204420003	Normal	-0.7
CPT0204360003	Normal	-0.7
CPT0204340003	Normal	-0.8
CPT0204410003	Normal	-0.8
Show allShow less

GLIOMA - Protein expressionⁱ A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here. Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

Antibody stainingⁱ Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells. Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.	Antibody HPA051759	Antibody HPA056990
Staining
High
Medium
Low
Not detected
Intensity
Strong
Moderate
Weak
Negative
Quantity
>75%
75%-25%
<25%
None
Location
Nuclear
Cytoplasmic/membranous
Cytoplasmic/membranous,nuclear
None
Glioma, malignant, High grade
Glioma, malignant, Low grade